Arrowhead Research | ARWR - Umsatzerlöse

Aktienkurs
73.46
Täglich Wechseln
2.93 4.15%
Monatlich
17.16%
Jährlich
423.22%
Q2 Prognose
72.33




Der Umsatz Veränderung Datum
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Incyte USD 1.27B 240M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
Merck USD 16.29B 110M 2026-03
Moderna USD 678M 342M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.11B 226M 2026-03
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
TG Therapeutics USD 192.57M 30.87M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Xencor USD 28.24M 7.24M 2025-12